Results 91 to 100 of about 17,319 (251)

Rules for Thee, Not for Me: Mass Attitudes on Judge Shopping

open access: yesSocial Science Quarterly, Volume 107, Issue 3, May 2026.
ABSTRACT Objective The goal of this project is to understand if the practice of judge shopping—strategically filing federal lawsuits to increase the likelihood of a favorable judge—raises concerns about fair judicial procedures. We examine how this practice reflects a broader loyalty‐fairness trade‐off in public evaluations of legal institutions, and ...
Miles T. Armaly, Elizabeth A. Lane
wiley   +1 more source

Clinical applications of mifepristone

open access: yes, 2006
Mifepristone is a progesterone antagonist that has been studied for a number of clinical applications. It is a well-known abortifacient that is effective for both first- and second-trimester medical abortion when used with a prostaglandin analog.
Ho, PC, Tang, OS
core   +1 more source

Exploring the Journey of Mifepristone in Canada and Australia

open access: yes, 2020
Mifepristone, also known by its drug development name RU486, is an anti-progestin that is part of the gold standard regimen of medication abortion. This medication is taken orally to induce an abortion through 70 days after the first day of the pregnant ...
LaRoche, Kathryn J.
core   +1 more source

Selection, counterselection, and conditional gene expression for genetic biocontrol of insects

open access: yesInsect Science, Volume 33, Issue 2, Page 724-743, April 2026.
Selection, counterselection, and conditional expression can be used for sex separation. Selection (S) and counterselection (CS) genes are linked to the sex chromosomes (e.g., the X and Y chromosomes) to confer sex‐specific selection or counterselection based on the presence or absence of the S or CS genes.
Melanie Hempel, Zhijian Tu
wiley   +1 more source

Depomedroxyprogesterone acetate impact on mifepristone action during medication abortion [PDF]

open access: yes
PurposeTo evaluate outcomes by gestational duration in patients who did and did not receive depomedroxyprogesterone acetate (DMPA) concurrently with mifepristone for mifepristone-misoprostol medication abortion and estimate the impact of DMPA on ...
Creinin, Mitchell D, Boraas, Christy M
core   +1 more source

A Cluster of Three snoRNAs Including Jouvence Required in the Gut Determines Lifespan and Confers Neuroprotection Through Metabolic Parameters

open access: yesAging Cell, Volume 25, Issue 4, April 2026.
The disruption of a cluster of three snoRNAs in the epithelium of the gut deregulates the lipid and sterol (including the cholesterol) homeostasis. At the whole‐organism level, this chronic deregulation, all along life, decreases lifespan and leads to neurodegenerative lesions in old flies.
Sara Al Issa   +4 more
wiley   +1 more source

Mifepristone 5 mg versus 10 mg for emergency contraception: double-blind randomized clinical trial

open access: yes, 2015
Josep Lluis Carbonell,1 Ramon Garcia,2 Adriana Gonzalez,2 Andres Breto,2 Carlos Sanchez2 1Mediterranea Medica Clinic, Valencia, Spain; 2Eusebio Hernandez Gynecology and Obstetrics Teaching Hospital, Havana, Cuba Purpose: To estimate the efficacy and ...
Carbonell JL   +4 more
core  

Mifepristone 2.5 mg versus 5 mg daily in the treatment of leiomyoma before surgery

open access: yes, 2012
Josep L Carbonell Esteve1, Ana M Riverón2, Mariela Cano2, Alma I Ortiz3, Aleta Valle2, Carlos S Texidó2, Giuseppe Tomasi41Mediterránea Médica Clinic, Valencia, Spain; 2Eusebio Hernández Obstetrics ...
Ortiz AI   +6 more
core  

Neuroprotective effect of mifepristone involves neuron depolarization

open access: yes, 2006
International audienceIn several regions of the developing nervous system, neurons undergo programmed cell death. In the rat cerebellum, Purkinje cell apoptosis is exacerbated when cerebellar slices are cultured during the first postnatal week.
Schumacher, M.   +8 more
core   +1 more source

Resistance to cisplatin does not affect sensitivity of human ovarian cancer cell lines to mifepristone cytotoxicity

open access: yesCancer Cell International, 2009
Background The prototypical antiprogestin mifepristone exhibits potent growth inhibition activity towards ovarian cancer cells in vitro and in vivo.
Seidel Erin E   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy